Wealth Enhancement Advisory Services LLC grew its holdings in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) by 11.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,009 shares of the real estate investment trust’s stock after buying an additional 398 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in National Health Investors were worth $284,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in NHI. NBC Securities Inc. boosted its stake in shares of National Health Investors by 24.6% in the second quarter. NBC Securities Inc. now owns 20,005 shares of the real estate investment trust’s stock valued at $1,402,000 after purchasing an additional 3,947 shares during the period. Strs Ohio purchased a new position in shares of National Health Investors in the first quarter valued at $598,000. Intech Investment Management LLC boosted its stake in shares of National Health Investors by 21.8% in the first quarter. Intech Investment Management LLC now owns 28,578 shares of the real estate investment trust’s stock valued at $2,111,000 after purchasing an additional 5,117 shares during the period. Jane Street Group LLC boosted its stake in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after purchasing an additional 21,851 shares during the period. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Stock Down 0.9%
Shares of NYSE:NHI opened at $75.03 on Thursday. The stock has a market capitalization of $3.56 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 3.26 and a beta of 0.77. National Health Investors, Inc. has a 1-year low of $65.13 and a 1-year high of $82.32. The company’s fifty day moving average is $76.94 and its two-hundred day moving average is $74.12. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.
National Health Investors Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a $0.92 dividend. This is a boost from National Health Investors’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.9%. National Health Investors’s dividend payout ratio is 117.57%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Cantor Fitzgerald assumed coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price for the company. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday. Wells Fargo & Company increased their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. Finally, National Bankshares set a $90.00 price objective on shares of National Health Investors in a research note on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $84.83.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
- Five stocks we like better than National Health Investors
- Stock Market Sectors: What Are They and How Many Are There?
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Top Biotech Stocks: Exploring Innovation Opportunities
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.